[HTML][HTML] The new progress in cancer immunotherapy
AS Shimu, H Wei, Q Li, X Zheng, B Li - Clinical and experimental medicine, 2023 - Springer
The cross talk between immune and non-immune cells in the tumor microenvironment leads
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
The new progress in cancer immunotherapy.
AS Shimu, H Wei, Q Li, X Zheng… - Clinical & Experimental …, 2023 - search.ebscohost.com
The cross talk between immune and non-immune cells in the tumor microenvironment leads
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
The new progress in cancer immunotherapy
AS Shimu, HX Wei, Q Li… - Clinical and …, 2023 - pubmed.ncbi.nlm.nih.gov
The cross talk between immune and non-immune cells in the tumor microenvironment leads
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
[PDF][PDF] The new progress in cancer immunotherapy
AS Shimu, H Wei, Q Li, X Zheng, B Li - 2022 - researchgate.net
The cross talk between immune and non-immune cells in the tumor microenvironment leads
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
The new progress in cancer immunotherapy.
AS Shimu, HX Wei, Q Li, X Zheng… - Clinical and Experimental …, 2022 - europepmc.org
The cross talk between immune and non-immune cells in the tumor microenvironment leads
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
[HTML][HTML] The new progress in cancer immunotherapy
AS Shimu, H Wei, Q Li, X Zheng, B Li - Clinical and Experimental …, 2023 - ncbi.nlm.nih.gov
The cross talk between immune and non-immune cells in the tumor microenvironment leads
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
The new progress in cancer immunotherapy.
AS Shimu, HX Wei, Q Li, X Zheng… - Clinical and Experimental …, 2022 - europepmc.org
The cross talk between immune and non-immune cells in the tumor microenvironment leads
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …
to immunosuppression, which promotes tumor growth and survival. Immunotherapy is an …